Headline
The latest stories from AHA Today.
The AHA today commended the Centers for Medicare & Medicaid Services for issuing proposed guidance to clarify ligature risk requirements and urged the agency to consider additional clarifying language.
The Medicare Payment Advisory Commission Friday issued its June report to Congress, which includes several recommendations approved by the panel during its January and March meetings.
Health and Human Services Secretary Alex Azar today announced he will promote Assistant Secretary for Public Affairs Judy Stecker to additionally serve as deputy chief of staff for operations and strategy, effective upon her return from maternity leave.
The AHA commented today on the Stopping the Outrageous Practice of Surprise Medical Bills (S. 1531), legislation developed by the Senate Bipartisan Working Group to address surprise medical bills.
The departments of Labor, Health and Human Services, and the Treasury yesterday finalized a rule that will allow employers to use health reimbursement arrangements to pay a portion of the premiums.
Between 2008 and 2017, the share of adults meeting the Physical Activity Guidelines for Americans increased from 19.4% to 25.3% among urban residents and from 13.3% to 19.6% among rural residents.
The Centers for Disease Control and Prevention today activated its Emergency Operations Center to support the interagency response to the Ebola outbreak in eastern Democratic Republic of the Congo, following confirmation of three travel-associated cases in Uganda.
The Senate Committee on the Judiciary, Subcommittee on Antitrust, Competition Policy, and Consumer Rights yesterday held a hearing on the competitive implications of vertical mergers in the health care sector.
Nine in 10 voters say access to health care in rural communities is important, and three in five would be more likely to vote for a candidate who prioritized it.
The Centers for Medicare & Medicaid Services yesterday approved a Medicaid state plan amendment allowing Washington state to negotiate supplemental rebate agreements with drug makers based on value.